Labiotech.eu

vigeneron germany gene therapy adenoviral vector

More News! 28 Nov 2019

German Biotech to Develop Next-Generation Gene Therapy for Blindness

The German biotech ViGeneron has raised an undisclosed sum in a Series A round to fund the development of an ophthalmic gene therapy that could deliver bigger DNA sequences into a wider range of cells than current technology. The round was led by two Chinese investors, the VC firm Sequoia Capital China and the pharma […]

November 28, 2019 - 2 minutesmins - By Jonathan Smith

shutterstock 144001390 min e1574774601179

Inside Labiotech 28 Nov 2019

How Remote Working Helps Us Become a Productive and Happy Team

‘For all those who are sitting in traffic right now.’ Today’s workers are tired of being tied to any one place. The standard 9-to-5 workday confined to a designated office doesn’t work for everyone anymore. Having flexible work options—such as the freedom to choose when, where, and how you perform your work—have become a growing […]

November 28, 2019 - 12 minutesmins - By Yi-Jen Chang

fragrance coniferol renewable plant waste

News and Trends 27 Nov 2019

Scientists Turn Crop Waste into Fragrances with Microbes

A team of researchers in Brazil and the UK has developed a fermentation technique to turn plant waste, such as wheat straw, into a valuable chemical used in the fragrance industry. In a study published in the journal Green Chemistry, the scientists used engineered Escherichia coli bacteria to break down sugar cane and wheat straw, […]

November 27, 2019 - 2 minutesmins - By Jonathan Smith

How to Address the Challenges of Biologics Discovery and Development

The biologics industry is growing at an incredible rate. While its global market value was estimated at $236B in 2017, it is expected to rise to $310B by 2023. As key market players enter the field, competition is increasing. In recent years, the biologics industry has become more versatile and has moved from being primarily […]

November 27, 2019 - 6 minutesmins - By External Contributor

lupus autoimmune disease neutrophil citryll

More News! 26 Nov 2019

Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III

A small molecule drug developed by the US company ChemoCentryx and its Swiss partner Vifor Fresenius Medical Care Renal Pharma (VFMCRP) was more effective at treating a rare inflammatory vascular disease than current treatments in a phase III trial. The drug avacopan was trialed in 331 patients with anti-neutrophil cytoplasmic antibody-associated vasculitis. This life-threatening condition […]

November 26, 2019 - 3 minutesmins - By Jonathan Smith

News and Trends 25 Nov 2019

Novartis Enters RNA Therapeutics with Medicines Company Merger

Novartis is to acquire The Medicines Company and its late-stage RNA interference drug designed to protect against cardiovascular disease in twice-yearly shots. Novartis will pay €8.8B ($9.7B) to acquire The Medicines Company, which is based in the US and focuses on developing the RNA drug inclisiran for the treatment of cardiovascular disease and renal impairment. […]

November 25, 2019 - 3 minutesmins - By Jonathan Smith

Jennie Ekbeck Umea Biotech Incubator e1575383377248

Interview 25 Nov 2019

Building a Life Science Industry from Scratch in a Small Swedish Town

Jennie Ekbeck has taken on the challenge of building Europe’s best life science incubator in Umeå, a small town in northern Sweden. Jennie Ekbeck became the CEO of the Umeå Biotech Incubator in 2012. Before that she was the CEO of a probiotics startup called Probac. “The reason why I applied to be the CEO […]

November 25, 2019 - 8 minutesmins - By Clara Rodríguez Fernández

News and Trends 22 Nov 2019

ViiV Healthcare Licenses Long-Acting Antibody to Attack Hidden HIV

The UK company ViiV Healthcare will begin a phase IIa trial of an antibody licensed from the National Institutes of Health in the US that could block HIV transmission for longer than current antiretroviral therapies. The antibody is currently in an ongoing phase I trial run by the National Institute of Allergy and Infectious Diseases, […]

November 22, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 21 Nov 2019

€37.4M Invested in Azeria Therapeutics’ Cancer Treatment Program

UK-based Azeria Therapeutics has raised a Series B investment round of €37.4M to fund development of novel breast cancer drugs targeting proteins called pioneer factors. The series B financing includes a €34.5M commitment from leading UK healthcare VC firm Syncona. The remainder was provided by the CRT Pioneer Fund — a specialist UK fund dedicated […]

November 21, 2019 - 3 minutesmins - By External Contributor

News and Trends 21 Nov 2019

Update: Swedish Medical Device Fails to Treat Spinal Cord Injury

Update (21/11/2019): The Swedish biotech BioArctic has terminated the clinical development of a biodegradable implant that is designed to treat spinal cord injury by encouraging the regrowth of nerve cells. The decision was made when an interim analysis in BioArctic’s phase I/II trial concluded that the treatment was ineffective. BioArctic will instead focus on developing […]

November 21, 2019 - 3 minutesmins - By Alexander Burik

More News! 20 Nov 2019

Spanish Researchers Produce Straws Made of Bacterial Bioplastic

An industry-academia collaboration in Spain has developed drinking straws based on a bioplastic produced by bacteria that are expected to enter the market in the next few months. The collaboration includes the company Ocenic Resins and the academic institutions Jaume I University and the Institute of Agrochemistry and Food Technology, all based in Spain. The […]

November 20, 2019 - 3 minutesmins - By Jonathan Smith

More News! 20 Nov 2019

€39M Series B to Fund Biopolymers for Surgery and Implants

The French company Tissium has raised a €38.8M Series B round to fund the development of polymers that can be used to repair blood vessels and nerves. Contributing to the round were newcomers to Tissium such as the European Investment Fund and returning investors such as the investment bank Bpifrance and French life sciences […]

November 20, 2019 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

German Biotech to Develop Next-Generation Gene Therapy for Blindness

How Remote Working Helps Us Become a Productive and Happy Team

Scientists Turn Crop Waste into Fragrances with Microbes

How to Address the Challenges of Biologics Discovery and Development

Rare Inflammatory Disease Drug Beats Immunosuppressants in Phase III

Novartis Enters RNA Therapeutics with Medicines Company Merger

Building a Life Science Industry from Scratch in a Small Swedish Town

ViiV Healthcare Licenses Long-Acting Antibody to Attack Hidden HIV

€37.4M Invested in Azeria Therapeutics’ Cancer Treatment Program

Update: Swedish Medical Device Fails to Treat Spinal Cord Injury

Spanish Researchers Produce Straws Made of Bacterial Bioplastic

€39M Series B to Fund Biopolymers for Surgery and Implants

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!